Get the Stockscreener App
6.01
6.62%
-0.49
Allurion Technologies Inc stock is traded at $6.01, with a volume of 143.35K.
It is down -6.62% in the last 24 hours and down -22.38% over the past month.
Allurion Technologies Inc is a medical device company that focuses on creating a best-in-class weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.
See More
Previous Close:
$6.50
Open:
$6.4
24h Volume:
143.35K
Relative Volume:
0.11
Market Cap:
$31.16M
Revenue:
$34.75M
Net Income/Loss:
$-24.76M
P/E Ratio:
-0.5008
EPS:
-12
Net Cash Flow:
$-50.91M
1W Performance:
+3.23%
1M Performance:
-22.38%
6M Performance:
-67.43%
1Y Performance:
-91.88%
1-Day Range:
$5.85
$6.49
1-Week Range:
$5.68
$7.1205
52-Week Range:
$2.3669
$98.75
Allurion Technologies Inc Stock (ALUR) Company Profile
Name
Allurion Technologies Inc
Sector
Industry
Phone
508-647-4000
Address
11 HURON DR STE 200, NATICK
Compare ALUR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALUR
Allurion Technologies Inc
|
6.11 | 31.16M | 34.75M | -24.76M | -50.91M | -12.00 |
|
ABT
Abbott Laboratories
|
129.27 | 222.39B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
105.58 | 154.78B | 15.91B | 1.79B | 1.89B | 1.21 |
|
SYK
Stryker Corp
|
392.70 | 150.99B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
90.01 | 116.46B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
71.22 | 41.87B | 6.60B | 4.16B | 490.10M | 6.93 |
Allurion Technologies Inc Stock (ALUR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-14-24 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Oct-02-24 | Initiated | TD Cowen | Buy |
| Sep-06-24 | Initiated | ROTH MKM | Buy |
| Feb-09-24 | Initiated | Jefferies | Buy |
Allurion Technologies Inc Stock (ALUR) Latest News
Allurion announces study on obesity treatment enhancement - MSN
12 Consumer Discretionary Stocks Moving In Tuesday's Pre-Market Session - Benzinga
This Little-Known Stock Just Doubled on Weight-Loss Drug News. Analysts Think It Has 400% Upside Potential From Here. - MSN
Eli Lilly and Company (LLY-N) QuotePress Release - The Globe and Mail
11 Consumer Discretionary Stocks Moving In Monday's Pre-Market Session - Benzinga
Allurion Technologies Soars 200% Amid Stock Offering and New Clinical Study Plans for Weight Loss Product - HPBL
Allurion Technologies Shares Surge as Company Eyes Obesity Drug Market with Gastric Balloon-GLP-1 Combo - HPBL
Why Logility Supply Chain Solutions Shares Are Trading Higher By Over 23%; Here Are 20 Stocks Moving Premarket - Benzinga
Allurion extends rally despite $7.4M stock and warrants offering - MSN
Allurion Soared Over 200% Today, But Is The Weight-Loss Stock A Buy? - Barchart
Allurion Catapults 200% On Its Plans To Outdo Eli Lilly, Novo Nordisk - MSN
Allurion Catapults 132% On Its Plans To Outdo Eli Lilly, Novo Nordisk - Yahoo! Voices
Allurion Technologies Shares Are Up Today: What's Going On? - Benzinga
Allurion Stock Triples on Plan to Test Gastric Balloon With Obesity Drugs - MSN
Allurion shares soar 77% after sharing plans for GLP-1RA combo trial - Yahoo Finance
Allurion Technologies Launches Stock Offering To Boost Growth - Evrim Ağacı
Allurion Technologies stock soars on clinical study announcement - MSN
Dow Falls 100 Points; US Manufacturing PMI Rises In January - Benzinga
Allurion Stock Explodes Following Clinical Study Announcement - Wall Street Pit
Allurion Shares Surge 185% Following $7.4 Million Fundraising Announcement - Yahoo Finance
Investors Are Buzzing! Major Breakthrough in Weight Loss Technology! - Jomfruland.net
Allurion Stock Skyrockets 80% After Hours Following Clinical Study Announcement - Yahoo Finance
Allurion Technologies' Stock Soars After Clinical Study Announcement - Evrim Ağacı
US Stocks Mixed; Verizon Posts Upbeat Sales - Benzinga
Allurion Technologies to sell 1.24M shares at $6 in registered direct offering - TipRanks
Allurion to Raise Approximately $7.4 Million of Gross Proceeds in Offering Priced At-the-Market - The Bakersfield Californian
Allurion Technologies stock soars on clinical study announcement By Investing.com - Investing.com Canada
Allurion announces study on obesity treatment enhancement By Investing.com - Investing.com Australia
12 Consumer Discretionary Stocks Moving In Friday's Pre-Market Session - Benzinga
US Stocks Set To Open Lower After Bank Of Japan Rate Hike: Analyst Recommends 'Overweight' Equities Despite Negative Market BreadthAllurion Technologies (NYSE:ALUR), American Airlines Gr (NASDAQ:AAL) - Benzinga
Allurion Stock Skyrockets on Weight-Loss Study Buzz - TipRanks
Allurion stock soars 70% on weight-loss therapy update - MSN
Stocks to Watch : Boeing, Texas Instruments, Allurion Technologies -January 23, 2025 at 07:12 pm EST - Marketscreener.com
Stocks to Watch: Boeing, Texas Instruments, Allurion Technologies - MarketWatch
Allurion Shares Rise 68% After Weight Loss Study News - MarketWatch
Allurion stock soars 70% on weight-loss therapy update (ALUR:NYSE) - Seeking Alpha
Allurion Technologies to initiate GLP-1 study optimizing for muscle mass - TipRanks
Allurion Announces Plans To Optimize Muscle Mass During GLP-1 Therapy In Combination With the Allurion Program - Marketscreener.com
Allurion secures new patent for gastric balloon technology By Investing.com - Investing.com Australia
Allurion gets ‘Notification of Issuance’ from USPTO for obesity treatment - TipRanks
Allurion secures new patent for gastric balloon technology - MSN
Allurion Announces Notification of Issuance of New U.S. Patent on Next-Generation Weight Loss Device for the Treatment of Obesity - Marketscreener.com
Allurion Technologies Inc Stock (ALUR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.94%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):